$169.43
0.180.11%
Last update: Nov 2, 3:57 PM
MERCK KGAA by Merck KGaA (MKGAF) Stock Price, Quote, News & History
MKGAFOTCPK
Silence Therapeutics (SLN) leaps 126% on a $1.3B cash acquisition by Merck KGaA at $20 per ADS. Deal expected to close Q1 2027.
You can purchase shares of MERCK KGAA by Merck KGaA (OTCPK:MKGAF) through any online brokerage.
There are no as such competitors for MERCK KGAA by Merck KGaA.
There is no analysis for MERCK KGAA by Merck KGaA to provide a consensus price target.
The stock price for MERCK KGAA by Merck KGaA (OTCPK: MKGAF) is $169.431 last updated November 2, 2026 at 3:57 PM EST.
There are no upcoming dividends for MERCK KGAA by Merck KGaA.
MERCK KGAA by Merck KGaA does not have any upcoming earnings scheduled.
There is no upcoming split for MERCK KGAA by Merck KGaA.
MERCK KGAA by Merck KGaA is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
Merck KGaA operates in three main segments: life science, electronics, and healthcare. The life science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry....
